Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Curr Opin Pharmacol. 2011 Jul 30;11(5):457–463. doi: 10.1016/j.coph.2011.07.001

Table 1.

Susceptibility breakpoints and chromosomal mutations associated with drug resistance

Drug Current breakpoint (mg/L) Proposed breakpoint (mg/L) Chromosomal mutations associated with resistance
Rifampin 1 0.0625 rpoB
Isoniazid 0.2/1.0 0.03/0.125 katC, inhA, oxyR, ahpC, furA
Streptomycin 5 - rrs, rpsL
Pyrazinamide 100 50 pncA
Ethambutol 5.0/7.5 4 embB
Moxifloxacin 1 1 gyrB